Healthcare Cold Chain Third Party Logistics Market To Reach $83.40 Billion By 2033

Healthcare Cold Chain Third Party Logistics Market Growth & Trends

The global healthcare cold chain third party logistics market size is expected to reach USD 83.40 billion by 2033, registering a CAGR of 7.74% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is driven by increasing reliance on biopharmaceuticals and other temperature-sensitive products. Biopharmaceuticals require stringent temperature controls to maintain efficacy, making cold chain logistics indispensable. Moreover, the growing prevalence of chronic diseases, along with the demand for precision medicine and gene therapies, has boosted the need for reliable temperature-controlled transportation. In addition, regulatory requirements for the storage and handling of biologics further emphasize the role of specialized logistics providers in ensuring compliance and product safety.

In addition, pharmaceutical and biopharmaceutical companies are increasingly focusing on expanding into emerging markets to strengthen their market position. Emerging countries are witnessing increasing demand for high-value drugs, necessitating robust cold storage and transportation networks. This expansion is driving investments in infrastructure, including temperature-controlled warehouses and specialized transportation fleets. In addition, strategic partnerships between pharmaceutical firms and 3PL providers are becoming more common to ensure seamless global distribution.

Key market players are adopting various strategies to strengthen their position in the healthcare cold chain logistics market. These include expanding global networks, investing in cutting-edge cold storage facilities, and leveraging digital solutions for enhanced tracking and compliance. Strategic mergers, acquisitions, and partnerships are also shaping the competitive landscape, allowing companies to extend their market reach and service capabilities. In February 2024, FedExmentioned its new FedEx Life Science Center in India, which will support the clinical trial logistics & storage requirements of healthcare customers in the Indian market & those shipping to India from around the world.

 Request a free sample copy or view report summary: Healthcare Cold Chain Third Party Logistics Market Report

Healthcare Cold Chain Third Party Logistics Market Report Highlights

• On the basis of service segment, the transportation segment captured the highest market share of 42.98% in 2025.

• On the basis of the product segment, the biopharmaceuticals segment dominated the industry in 2025.

• On the basis of temperature range, the frozen segment dominated the industry in 2025. The segment’s growth is due to the high volume of biologics, vaccines, and specialty pharmaceuticals that require storage temperatures between -20°C and -80°C.

• On the basis of the end use, the pharmaceutical and biopharmaceutical companies segment dominated the industry in 2025.

• North America market held the largest market share of 38.20% in 2025. This growth can be attributed to its advanced pharmaceutical industry and well regulatory framework. The region is witnessing significant investments in temperature-controlled warehouses, AI-driven route optimization and growing strategic initiatives by key players.

Healthcare Cold Chain Third Party Logistics Market Segmentation

Grand View Research has segmented the global healthcare cold chain third party logistics market on the basis of on service, product, temperature range, end use, and region:

Healthcare Cold Chain Third Party Logistics Service Outlook (Revenue, USD Million, 2021 - 2033)

• Transportation

  • Air Freight

  • Sea Freight

  • Overland

• Warehousing & Storage

• Packaging Solutions

• Monitoring & Visibility Solutions

• Inventory Management

• Others

Healthcare Cold Chain Third Party Logistics Product Outlook (Revenue, USD Million, 2021 - 2033)

• Biopharmaceuticals

• Pharmaceuticals

• Medical Device

• Others

Healthcare Cold Chain Third Party Logistics Temperature Range Outlook (Revenue, USD Million, 2021 - 2033)

• Frozen

• Ultra-frozen/Deep-Frozen

• Cryogenic

Healthcare Cold Chain Third Party Logistics End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical & Biopharmaceutical Companies

• Medical Device Companies

• Others

Healthcare Cold Chain Third Party Logistics Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy 

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand 

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Oman

  • Qatar

List of Key Players in the Healthcare Cold Chain Third Party Logistics Market

• Cardinal Health

• DHL

• Agility

• SF Express

• Kinesis

• UPS

• Barrett Distribution Centers

• AmerisourceBergen

• DB Schenker

• FedEx

• KUEHNE + NAGEL